Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-11-05
1992-11-10
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 34, 435119, A61K 31445, C07D491044, C07D49108
Patent
active
051623307
ABSTRACT:
The novel antitumor antibiotic designated herein as dynemicin C is produced by fermentation of Micromonospora chersina M956-1 mutant F1085 (ATCC-55077). Dynemicin C and its triacetate derivative possess antibacterial and antifungal activity and also inhibit the growth of mammalian tumors.
REFERENCES:
patent: 4916065 (1990-04-01), Ohkuma et al.
Miyaki Takeo
Oda Nahomi
Saitoh Kyoichiro
Yamamoto Haruaki
Bristol-Myers Squibb Co.
Morse David M.
Rotman Alan L.
LandOfFree
Dynemicin C antibiotic, its triacetyl derivative and pharmaceuti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dynemicin C antibiotic, its triacetyl derivative and pharmaceuti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dynemicin C antibiotic, its triacetyl derivative and pharmaceuti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2292919